UPDATE : Thursday, October 17, 2019
EU approves Abbvie’s Humira as first biologic to treat CHMP
Abbvie Korea, the Korean offshoot of the global biopharmaceutical company, ...
by Marian Chu  |  2017-09-12 15:45
FIP head calls for revitalizing generic substitution
International Pharmaceutical Federation (FIP) has come forward to emphasize...
by Lee Hye-seon  |  2017-09-12 14:34
Lilly’s diabetes drug ahead of Novo Nordisk’s in Q2 market share
Lilly Korea’s diabetes drug Trulicity grabbed the largest market share in K...
by Marian Chu  |  2017-09-12 13:26
Sillajen stock surges upon clinical trial announcement
The share price of Sillajen, a biopharmaceutical company, has been surging ...
by Lee Han-soo  |  2017-09-12 13:26
Ildong, Olix agree to develop new drugs
Ildong Pharmaceutical and Olix Pharmaceuticals, an RNA interference (RNAi)-...
by Lee Han-soo  |  2017-09-11 17:30
Abbvie lands 1st place on Dow Jones Sustainability Index
Global biopharmaceutical Abbvie said Monday it has ranked number one, for t...
by Marian Chu  |  2017-09-11 14:38
GSK’s HIV drug ranked No. 1 in Q2 sales
GlaxoSmithKline (GSK) said Monday its human immunodeficiency virus (HIV) tr...
by Marian Chu  |  2017-09-11 14:37
FDA orders halt on Opidvo trials
Two months after the U.S. Food and Drug Administration halted Merck & Co’s ...
by Marian Chu  |  2017-09-08 16:39
Vivus, Alvogen sign agreement to market diet treatment in Korea
Alvogen Korea 알보젠코리아, a pharmaceutical company, announced Friday that it ha...
by Lee Han-soo  |  2017-09-08 15:24
Teva-Handok wins approval for anti-asthma injection
The Ministry of Food and Drug Safety (MFDS) approved Teva-Handok’s injectio...
by Marian Chu  |  2017-09-07 14:58
Novartis Korea gains approval for skin disease biologic
The Ministry of Food and Drug Safety (MFDS) has approved biologic Xolair to...
by Marian Chu  |  2017-09-07 14:28
Green Cross Cell, Maryland to cooperate for US business
Green Cross Cell, a cell treatment company, announced Wednesday that it has...
by Lee Han-soo  |  2017-09-07 11:18
BMS, Pfizer prove safety for blood-thinning drug in P4 trial
Bristol-Myers Squibb and Pfizer said Wednesday their blood thinner drug Eli...
by Marian Chu  |  2017-09-06 17:40
Novartis’ Revolade proved effective for seniors
Novartis Korea said Tuesday additional data analysis from its EXTEND clinic...
by Marian Chu  |  2017-09-06 12:53
GemVax & KAEL names Song as new CEO
GemVax & KAEL has appointed Song Hyoung-gon 송형곤 as their new chief executiv...
by Lee Han-soo  |  2017-09-06 10:47
Will Amgen’s Repatha succeed in the Korean market?
Amgen Korea released its cholesterol-lowering drug Repatha in the domestic ...
by Marian Chu  |  2017-09-06 09:07
Pfizer Korea releases new tool for rheumatism injection
Pfizer Korea said Tuesday it has released an injection tool and program cal...
by Marian Chu  |  2017-09-05 17:22
‘Mooncare’ helps bio, pharmaceutical stocks overcome NK risks
Amid escalating North Korea risks caused by the North’s nuclear and missile...
by Nam Doo-hyun  |  2017-09-05 16:45
Celgene Korea names new CEO
Celgene Korea has elected Ham Tae-jin as its new CEO, the company said Tues...
by Marian Chu  |  2017-09-05 14:22
Korean start-up Sky Labs wins in Bayer innovation program
Bayer (CEO: Werner Baurmann) said Tuesday it selected four startups, includ...
by Marian Chu  |  2017-09-05 11:11
Back to Top